Mild gut inflammation modulates the proteome of intestinal Escherichia coli

Environmental Microbiology

Volumn 16, Issue 9, 2014, Pages 2966-2979

  Schumann, Sara ^a   Alpert, Carl ^a   Engst, Wolfram ^a   Klopfleisch, Robert ^b   Loh, Gunnar ^a   Bleich, André ^c   Blaut, Michael ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI; HEDERA; MUS; VERTEBRATA;

BACTERIAL RNA; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; INTERLEUKIN 10; IVY PROTEIN, E COLI; PROBIOTIC AGENT; PROTEOME;

ANIMAL; C3H MOUSE; CECUM; ESCHERICHIA COLI; GENETICS; INFLAMMATION; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY;

ANIMALS; CARRIER PROTEINS; CECUM; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; INFLAMMATION; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; PROBIOTICS; PROTEOME; RNA, BACTERIAL;

EID: 84906944891     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/1462-2920.12192     Document Type: Article

References (34)

1. Abergel, C., Monchois, V., Byrne, D., Chenivesse, S., Lembo, F., Lazzaroni, J.C., and Claverie, J.M. (2007) Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria. Proc Natl Acad Sci USA 104: 6394-6399.
2. Berg, D.J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., etal. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020.
3. Bristol, I.J., Farmer, M.A., Cong, Y., Zheng, X.X., Strom, T.B., Elson, C.O., etal. (2000) Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis 6: 290-302.
4. Burich, A., Hershberg, R., Waggie, K., Zeng, W., Brabb, T., Westrich, G., etal. (2001) Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281: G764-G778.
5. Callewaert, L., Aertsen, A., Deckers, D., Vanoirbeek, K.G., Vanderkelen, L., Van Herreweghe, J.M., etal. (2008) A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog 4: e1000019.
6. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., etal. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115: 1405-1413.
7. Deckers, D., Masschalck, B., Aertsen, A., Callewaert, L., Van Tiggelen, C.G., Atanassova, M., and Michiels, C.W. (2004) Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli. Cell Mol Life Sci 61: 1229-1237.
8. Grozdanov, L., Raasch, C., Schulze, J., Sonnenborn, U., Gottschalk, G., Hacker, J., and Dobrindt, U. (2004) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186: 5432-5441.
9. Kim, S.C., Tonkonogy, S.L., Albright, C.A., Tsang, J., Balish, E.J., Braun, J., etal. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891-906.
10. Kitagawa, M., Matsumura, Y., and Tsuchido, T. (2000) Small heat shock proteins, IbpA and IbpB, are involved in resistances to heat and superoxide stresses in Escherichia coli. FEMS Microbiol Lett 184: 165-171.
11. Kruis, W., Schutz, E., Fric, P., Fixa, B., Judmaier, G., and Stolte, M. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11: 853-858.
12. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., etal. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
13. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
14. Lehrer, R.I., Barton, A., Daher, K.A., Harwig, S.S., Ganz, T., and Selsted, M.E. (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 84: 553-561.
15. Loh, G., and Blaut, M. (2012) Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes 3: 544-555.
16. Marshall, O.J. (2004) PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20: 2471-2472.
17. Monchois, V., Abergel, C., Sturgis, J., Jeudy, S., and Claverie, J.M. (2001) Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J Biol Chem 276: 18437-18441.
18. Möndel, M., Schroeder, B.O., Zimmermann, K., Huber, H., Nuding, S., Beisner, J., etal. (2009) Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2: 166-172.
19. Mostertz, J., Scharf, C., Hecker, M., and Homuth, G. (2004) Transcriptome and proteome analysis of Bacillus subtilis gene expression in response to superoxide and peroxide stress. Microbiology 150: 497-512.
20. Nagalingam, N.A., Kao, J.Y., and Young, V.B. (2011) Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 17: 917-926.
21. Nossal, N.G., and Heppel, L.A. (1966) The release of enzymes by osmotic shock from Escherichia coli in exponential phase. J Biol Chem 241: 3055-3062.
22. Ogawa, H., Fukushima, K., Naito, H., Funayama, Y., Unno, M., Takahashi, K., etal. (2003) Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 9: 162-170.
23. Patwa, L.G., Fan, T.J., Tchaptchet, S., Liu, Y., Lussier, Y.A., Sartor, R.B., and Hansen, J.J. (2011) Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 141: 1842-1851. e1841-1810.
24. Redon, E., Loubiere, P., and Cocaign-Bousquet, M. (2005) Role of mRNA stability during genome-wide adaptation of Lactococcus lactis to carbon starvation. J Biol Chem 280: 36380-36385.
25. Rembacken, B.J., Snelling, A.M., Hawkey, P.M., Chalmers, D.M., and Axon, A.T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635-639.
26. Rothe, M., Alpert, C., Loh, G., and Blaut, M. (2013) Novel insights into E. coli's hexuronate metabolism: kdui facilitates the conversion of galacturonate and glucuronate under osmotic stress conditions. PLoS ONE 8: e56906.
27. Sasaki, M., Sitaraman, S.V., Babbin, B.A., Gerner-Smidt, P., Ribot, E.M., Garrett, N., etal. (2007) Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 87: 1042-1054.
28. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F., and Fellermann, K. (2007) Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 75: 2399-2407.
29. Schumann, S., Alpert, C., Engst, W., Loh, G., and Blaut, M. (2012) Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol 78: 1513-1522.
30. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., etal. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
31. Vanderkelen, L., Ons, E., Van Herreweghe, J.M., Callewaert, L., Goddeeris, B.M., and Michiels, C.W. (2012) Role of lysozyme inhibitors in the virulence of avian pathogenic Escherichia coli. PLoS ONE 7: e45954.
32. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
33. Vogel-Scheel, J., Alpert, C., Engst, W., Loh, G., and Blaut, M. (2010) Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl Environ Microbiol 76: 5181-5187.
34. Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., etal. (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72: 5750-5758.